Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Weed (BUDZ) EBIT (2017 - 2025)

Weed has reported EBIT over the past 12 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly results put EBIT at -$1.9 million for Q4 2025, down 313.58% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (down 601.29% YoY), and the annual figure for FY2025 was -$1.3 million, down 360.17%.
  • EBIT for Q4 2025 was -$1.9 million at Weed, down from -$66897.0 in the prior quarter.
  • Over the last five years, EBIT for BUDZ hit a ceiling of $912847.0 in Q4 2024 and a floor of -$1.9 million in Q4 2025.
  • Median EBIT over the past 5 years was -$183908.0 (2023), compared with a mean of -$341458.5.
  • Biggest five-year swings in EBIT: skyrocketed 2887.66% in 2024 and later plummeted 313.58% in 2025.
  • Weed's EBIT stood at -$169910.0 in 2021, then tumbled by 70.01% to -$288861.0 in 2022, then soared by 88.66% to -$32746.0 in 2023, then skyrocketed by 2887.66% to $912847.0 in 2024, then plummeted by 313.58% to -$1.9 million in 2025.
  • The last three reported values for EBIT were -$1.9 million (Q4 2025), -$66897.0 (Q3 2025), and -$94045.0 (Q2 2025) per Business Quant data.